Skip to main content
 

Jayne Morgan, MD

Jayne Morgan, MD

Dr. Jayne Morgan is an accomplished Cardiologist and the Vice President of Medical Affairs for Hello Heart where she has a focus on Women’s Health among many other things. With both an interest in menopause and women’s well being, Dr. Morgan was recently named by MidiHealth to the 45 over 45 list of top Women’s Health experts. A long supporter and advocate for health equity challenges with a focus on the recruitment of minority populations into clinical trials, she considers research, specifically cardiovascular research, to be her bread and butter foundation.

In fact, with an extensive background in clinical trials and cardiac research, Dr. Morgan has made significant contributions to patient care and medical advancement throughout her career. Her expertise encompasses not only the assessment and treatment of various cardiac conditions, including heart disease, arrhythmias, and heart failure, but she is also highly regarded for her exceptional skills in the interpretation of complex medical data.

Previously, Dr. Morgan served as the Executive Director of Health and Community Education at the Piedmont Healthcare Corporation, located in Atlanta, GA. As the largest healthcare system in Georgia, Dr. Morgan played a pivotal role in addressing health literacy and disseminating information both within the organization, which employs 47,000 individuals, and to external stakeholders, including leading the Covid Task Force. She has published multiple papers on both Cardiology as well as Covid-19 working to increase both accurate knowledge and awareness. One of her notable contributions was the creation of a social media series called “The Stairwell Chronicles,” providing up-to-date medical and scientific information in an easily understandable format.

More News

  • AI-powered tool may offer contactless way to detect high blood pressure, diabetes

  • Primary care professionals key to helping people achieve & maintain heart health

  • Innovators’ Network Member Cleerly Closes New Round of Funding